Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MultiGeneAngio in Peripheral Arterial Disease
NCT00390767Phase 2Unknown
- Sponsor
- MultiGene Vascular Systems
- Start
- Oct 2006
- Primary completion
- Dec 2010
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MultiGeneAngio in Peripheral Arterial Disease (PAD), sponsored by MultiGene Vascular Systems. Status: unknown.
02
Drugs
MultiGeneAngio
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00390767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390767.